- Chromogenix Coamatic® Factor VIII (K822585)
- Chromogenix Coatest® SP Factor VIII (K824086)
- Chromogenix Coatest® SP4 Factor VIII (K824094)
Main Features:
- In complete compliance with the European Pharmacopoeia chromogenic reference method for analysis of factor VIII concentrates
- Co-lyophilization of reagents for convenient handling
- Inclusion of Thrombin for immediate activation of factor VIII
- Reliable tool for hemophilia classification; no interference from heparin levels up to 1.0 IU/ml
- S-2765, the most sensitive factor Xa-substrate
- Instrument applications available – FDA cleared
Suitable For:
- Potency determination of factor VIII concentrates in quality control
- Hemophilia diagnosis and monitoring
- Thrombophilia screening (elevated factor VIII)
Main Features:
- The first validated chromogenic assay for factor VIII activity
- Stable and robust reagents which contributes to make this the most common chromogenic assay in QC worldwide
- High flexibility in setting optimal experimental conditions
- In compliance with the European Pharmacopoeia chromogenic reference method for analysis of factor VIII concentrate
- Designed for high volume (Coatest® SP FVIII) or low volume (Coatest SP4® FVIII) testing – FDA cleared
Suitable For:
- Potency determination of factor VIII concentrates in quality control
- Hemophilia diagnosis and monitoring
Kit | Substrate | Type of Samples | Measuring Ranges | No. of Tests |
---|---|---|---|---|
Chromogenix Coamatic® Factor VIII | S-2765 | Human plasma Blood fractions Purified preparations | Elevated: 1-4 IU/ml Normal: 0.05-1.5 IU/ml Low: 0.005-0.05 IU/ml | Test tube: 30 Microplate: 120 Automated: up to 100 |
Chromogenix Coatest® SP Factor VIII Chromogenix Coatest® SP4 Factor VIII | S-2765 | Human plasma Blood fractions Purified preparations | Normal: 0.2-1.5 IU/ml Low: 0.01-0.2 IU/ml | Test tube: 60 Microplate: 240 Automated: up to 200 |
Distributed in North America by: DiaPharma Group, Inc.